Shots:
- UCB invested $29.3M in Nile and as majority shareholder, will be the Board of Directors of Nile with future opportunities to acquire insights and data from Nile’s platform
- Nile is developing a digital epilepsy care management platform and bringing together data to make the epilepsy journey predictable. The platform consists of patient app and HCP portal & is anticipated to be commercially available in 2021
- Nile’s platform will serve as a digital extension of the HCPs with an aim of shortening the path to optimal treatment
Click here to read full press release/ article | Ref: UCB | Image: Pharmaphorum
The post UCB Launches Nile AI as a Digital Health Company to Transform the Course of Epilepsy first appeared on PharmaShots.
